Loading insider details...
Beta
Latest Form 4 (Aug 26, 2026): Sale of 5,062 ATRA shares, $40.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 5,062 | $40.9K |
| May 20, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 5,241 | $47.8K |
| Mar 11, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 81,100 | n/a |
| Mar 4, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 198 | $1.0K |
| Nov 19, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 2,859 | $37.7K |
| Aug 20, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 57 | $661.94 |
| May 20, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 3,276 | $22.2K |
| Mar 5, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 3,331 | $23.3K |
| Nov 20, 2024 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 1,664 | $18.6K |
| Sep 11, 2024 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 45,000 | n/a |